vs
AvePoint（AVPT）与REPLIGEN CORP（RGEN）财务数据对比。点击上方公司名可切换其他公司
REPLIGEN CORP的季度营收约是AvePoint的1.7倍（$197.9M vs $114.7M），AvePoint净利率更高（13.6% vs 6.7%，领先6.9%），AvePoint同比增速更快（28.6% vs 13.6%），AvePoint自由现金流更多（$29.0M vs $17.6M），过去两年AvePoint的营收复合增速更高（24.0% vs 14.4%）
AvePoint是一家总部位于美国新泽西州泽西市的企业，成立于2001年，2020年在纳斯达克上市。公司专注于开发软件产品，为Microsoft 365、谷歌、Salesforce等主流平台提供功能拓展与安全增强解决方案，服务全球各行业客户的数字化协作与数据治理需求。
Repligen是一家全球生命科学企业，专注于创新生物工艺技术与系统的研发及商业化，助力提升生物药生产效率。公司1981年成立，总部位于美国马萨诸塞州沃尔瑟姆，于纳斯达克挂牌上市，股票代码RGEN，截至2025年全球员工超1900人，主要服务生物制药领域客户。
AVPT vs RGEN — 直观对比
营收规模更大
RGEN
是对方的1.7倍
$114.7M
营收增速更快
AVPT
高出15.0%
13.6%
净利率更高
AVPT
高出6.9%
6.7%
自由现金流更多
AVPT
多$11.4M
$17.6M
两年增速更快
AVPT
近两年复合增速
14.4%
损益表 — Q4 FY2025 vs Q4 FY2025
| 指标 | | |
|---|---|---|
| 营收 | $114.7M | $197.9M |
| 净利润 | $15.6M | $13.3M |
| 毛利率 | 73.6% | 52.5% |
| 营业利润率 | 12.7% | 9.0% |
| 净利率 | 13.6% | 6.7% |
| 营收同比 | 28.6% | 13.6% |
| 净利润同比 | 191.1% | 143.9% |
| 每股收益（稀释后） | $0.06 | $0.24 |
绿色 = 该指标领先。财年不对齐时期间可能不同
8季度营收与利润趋势
并排季度历史对比，按日历期对齐，财年错位的公司也能正确匹配
营收AVPTRGEN
| Q4 25 | $114.7M | $197.9M | ||
| Q3 25 | $109.7M | $188.8M | ||
| Q2 25 | $102.0M | $182.4M | ||
| Q1 25 | $93.1M | $169.2M | ||
| Q4 24 | $89.2M | $174.1M | ||
| Q3 24 | $88.8M | $154.9M | ||
| Q2 24 | $78.0M | $154.1M | ||
| Q1 24 | $74.5M | $151.3M |
净利润AVPTRGEN
| Q4 25 | $15.6M | $13.3M | ||
| Q3 25 | $13.0M | $14.9M | ||
| Q2 25 | $2.9M | $14.9M | ||
| Q1 25 | $3.6M | $5.8M | ||
| Q4 24 | $-17.2M | $-30.3M | ||
| Q3 24 | $2.6M | $-654.0K | ||
| Q2 24 | $-12.9M | $3.3M | ||
| Q1 24 | $-2.0M | $2.1M |
毛利率AVPTRGEN
| Q4 25 | 73.6% | 52.5% | ||
| Q3 25 | 74.4% | 53.2% | ||
| Q2 25 | 74.0% | 50.0% | ||
| Q1 25 | 74.3% | 53.6% | ||
| Q4 24 | 75.4% | 26.1% | ||
| Q3 24 | 76.1% | 50.0% | ||
| Q2 24 | 75.7% | 49.8% | ||
| Q1 24 | 72.6% | 49.5% |
营业利润率AVPTRGEN
| Q4 25 | 12.7% | 9.0% | ||
| Q3 25 | 7.4% | 8.9% | ||
| Q2 25 | 7.0% | 7.6% | ||
| Q1 25 | 3.5% | 3.9% | ||
| Q4 24 | 5.4% | -17.7% | ||
| Q3 24 | 8.6% | -5.1% | ||
| Q2 24 | -2.7% | 1.0% | ||
| Q1 24 | -4.3% | 1.3% |
净利率AVPTRGEN
| Q4 25 | 13.6% | 6.7% | ||
| Q3 25 | 11.9% | 7.9% | ||
| Q2 25 | 2.8% | 8.2% | ||
| Q1 25 | 3.8% | 3.4% | ||
| Q4 24 | -19.3% | -17.4% | ||
| Q3 24 | 3.0% | -0.4% | ||
| Q2 24 | -16.6% | 2.2% | ||
| Q1 24 | -2.6% | 1.4% |
每股收益（稀释后）AVPTRGEN
| Q4 25 | $0.06 | $0.24 | ||
| Q3 25 | $0.06 | $0.26 | ||
| Q2 25 | $0.01 | $0.26 | ||
| Q1 25 | $0.02 | $0.10 | ||
| Q4 24 | $-0.09 | $-0.55 | ||
| Q3 24 | $0.01 | $-0.01 | ||
| Q2 24 | $-0.07 | $0.06 | ||
| Q1 24 | $-0.01 | $0.04 |
资产负债表与财务实力
最新季度各公司的流动性、杠杆与账面价值一览
| 指标 | | |
|---|---|---|
| 现金及短期投资手头流动性 | $481.1M | $767.6M |
| 总债务越低越好 | — | $542.2M |
| 股东权益账面价值 | $478.7M | $2.1B |
| 总资产 | $789.2M | $2.9B |
| 负债/权益比越低杠杆越低 | — | 0.26× |
8季度趋势，按日历期对齐
现金及短期投资AVPTRGEN
| Q4 25 | $481.1M | $767.6M | ||
| Q3 25 | $471.6M | $748.7M | ||
| Q2 25 | $430.1M | $708.9M | ||
| Q1 25 | $351.8M | $697.2M | ||
| Q4 24 | $290.9M | $757.4M | ||
| Q3 24 | $250.0M | $784.0M | ||
| Q2 24 | $230.8M | $809.1M | ||
| Q1 24 | $219.3M | $780.6M |
总债务AVPTRGEN
| Q4 25 | — | $542.2M | ||
| Q3 25 | — | $537.9M | ||
| Q2 25 | — | — | ||
| Q1 25 | — | — | ||
| Q4 24 | — | $525.6M | ||
| Q3 24 | — | — | ||
| Q2 24 | — | — | ||
| Q1 24 | — | — |
股东权益AVPTRGEN
| Q4 25 | $478.7M | $2.1B | ||
| Q3 25 | $466.8M | $2.1B | ||
| Q2 25 | $443.1M | $2.1B | ||
| Q1 25 | $361.5M | $2.0B | ||
| Q4 24 | $270.9M | $2.0B | ||
| Q3 24 | $215.7M | $2.0B | ||
| Q2 24 | $207.4M | $2.0B | ||
| Q1 24 | $212.7M | $2.0B |
总资产AVPTRGEN
| Q4 25 | $789.2M | $2.9B | ||
| Q3 25 | $743.5M | $2.9B | ||
| Q2 25 | $700.1M | $2.9B | ||
| Q1 25 | $598.8M | $2.9B | ||
| Q4 24 | $519.1M | $2.8B | ||
| Q3 24 | $463.0M | $2.8B | ||
| Q2 24 | $427.3M | $2.9B | ||
| Q1 24 | $413.8M | $2.8B |
负债/权益比AVPTRGEN
| Q4 25 | — | 0.26× | ||
| Q3 25 | — | 0.26× | ||
| Q2 25 | — | — | ||
| Q1 25 | — | — | ||
| Q4 24 | — | 0.27× | ||
| Q3 24 | — | — | ||
| Q2 24 | — | — | ||
| Q1 24 | — | — |
现金流与资本效率
扣除再投资后实际产生的现金。现金流比净利润更难造假
| 指标 | | |
|---|---|---|
| 经营现金流最新季度 | $29.7M | $25.7M |
| 自由现金流经营现金流 - 资本支出 | $29.0M | $17.6M |
| 自由现金流率自由现金流/营收 | 25.3% | 8.9% |
| 资本支出强度资本支出/营收 | 0.6% | 4.1% |
| 现金转化率经营现金流/净利润 | 1.90× | 1.93× |
| 过去12个月自由现金流最近4个季度 | $81.6M | $93.9M |
8季度趋势，按日历期对齐
经营现金流AVPTRGEN
| Q4 25 | $29.7M | $25.7M | ||
| Q3 25 | $34.8M | $48.1M | ||
| Q2 25 | $20.3M | $28.6M | ||
| Q1 25 | $495.0K | $15.0M | ||
| Q4 24 | $32.8M | $39.2M | ||
| Q3 24 | $32.2M | $49.3M | ||
| Q2 24 | $16.2M | $42.2M | ||
| Q1 24 | $7.8M | $44.7M |
自由现金流AVPTRGEN
| Q4 25 | $29.0M | $17.6M | ||
| Q3 25 | $34.3M | $43.4M | ||
| Q2 25 | $19.3M | $21.5M | ||
| Q1 25 | $-1.0M | $11.4M | ||
| Q4 24 | $32.0M | $33.6M | ||
| Q3 24 | $30.8M | $42.3M | ||
| Q2 24 | $15.8M | $37.4M | ||
| Q1 24 | $7.3M | $36.4M |
自由现金流率AVPTRGEN
| Q4 25 | 25.3% | 8.9% | ||
| Q3 25 | 31.3% | 23.0% | ||
| Q2 25 | 18.9% | 11.8% | ||
| Q1 25 | -1.1% | 6.8% | ||
| Q4 24 | 35.9% | 19.3% | ||
| Q3 24 | 34.7% | 27.3% | ||
| Q2 24 | 20.2% | 24.3% | ||
| Q1 24 | 9.7% | 24.0% |
资本支出强度AVPTRGEN
| Q4 25 | 0.6% | 4.1% | ||
| Q3 25 | 0.5% | 2.5% | ||
| Q2 25 | 0.9% | 3.9% | ||
| Q1 25 | 1.6% | 2.1% | ||
| Q4 24 | 0.8% | 3.2% | ||
| Q3 24 | 1.6% | 4.5% | ||
| Q2 24 | 0.5% | 3.1% | ||
| Q1 24 | 0.7% | 5.5% |
现金转化率AVPTRGEN
| Q4 25 | 1.90× | 1.93× | ||
| Q3 25 | 2.68× | 3.23× | ||
| Q2 25 | 7.01× | 1.92× | ||
| Q1 25 | 0.14× | 2.57× | ||
| Q4 24 | — | — | ||
| Q3 24 | 12.30× | — | ||
| Q2 24 | — | 12.70× | ||
| Q1 24 | — | 21.35× |
财务流量对比
营收 → 毛利润 → 营业利润 → 净利润流向图
业务分部营收拆解
AVPT
| SAAS | $88.9M | 78% |
| Services | $14.7M | 13% |
| Termed License And Support | $10.1M | 9% |
RGEN
暂无分部数据
